Tom Wilemon

Michael Gibson, MD, PhD
October 30, 2024

Michael Gibson votes with FDA panel to limit immunotherapy indication 

The panel determined that allowing the wider indication would put patients at risk for adverse reactions from the two immunotherapies but without the added benefit in survival. 

By Tom Wilemon
October 24, 2024

Same day appointments can be made for mammograms 

No referral from a primary care provider is required to book an appointment for a screening mammogram, but you must already have a medical chart set up at VUMC for the same-day service.

By Tom Wilemon
October 22, 2024

Scott Zuckerman receives Credo Award for communication and commitment to colleagues

“The care we deliver in surgery is simply not possible without this army of devoted individuals.”

By Tom Wilemon
Cathy Eng, MD
October 15, 2024

Cathy Eng named Vanderbilt-Ingram Cancer Center associate director of Strategic Relations and Research Partnerships 

Her new responsibilities will include promoting clinical research by developing new strategic partnerships with pharmaceutical and biotech companies.

By Tom Wilemon
color-enhanced cross section of tumor tissue
October 7, 2024

New Video: Study shows cancer vaccine blocks tumor progression at early lesion stage

Senior author Mary Philip, MD, PhD, associate director of the Vanderbilt Institute for Infection, Immunology and Inflammation, talks about her Journal for ImmunoTherapy of Cancer study.
The findings support further vaccine investigation to make long-term, progression-free survival a reality for more cancer patients.

By Tom Wilemon
October 7, 2024

VUMC hosts International Lung Cancer Consortium meeting 

The consortium is coordinated by the International Agency for Research on Cancer with the aim of sharing data from ongoing lung cancer case-control and cohort studies.

By Tom Wilemon
October 4, 2024

‘Off-the-shelf’ CAR-T therapy shows promise for relapsed/refractory multiple myeloma 

The therapy, P-BCMA-ALL01, demonstrated a 91% overall response rate for the 23 patients participating in the phase 1 trial.
By Tom Wilemon
October 2, 2024

Grant funds quest to expand immunotherapy efficacy for colorectal cancer  

The study seeks to understand the mechanisms of colorectal cancer and builds on recent Vanderbilt research.
By Tom Wilemon
September 27, 2024

Vanderbilt-Ingram Cancer Center part of new ‘Rewriting Cancer’ series

Launched Sept. 17-19 during the World Cancer Congress in Geneva, Switzerland, “Rewriting Cancer” aims to enhance understanding and inspire audiences by exploring the most innovative, inclusive and impactful solutions for cancer prevention, diagnosis, treatment and care globally.
By Tom Wilemon
September 20, 2024

Vanderbilt researchers speaks at World Conference on Lung Cancer

Deppen spoke about biological, population and technology issues related to the discovery and implementation of biomarkers for early cancer detection.
By Tom Wilemon
September 17, 2024

Protocol improves follow-up for women at high risk for breast cancer 

Before the protocol, every patient underwent a Breast Cancer Risk Assessment Tool evaluation, yet there was no established protocol for sharing the results.
By Tom Wilemon
August 28, 2024

Vanderbilt and OHSU join forces to train addiction research scholars 

The new training program’s participants will focus their research efforts on substance use with an emphasis on vulnerable populations, such as people living with HIV.
By Tom Wilemon
1 … 4 5 6 7 8 … 39